NCT03162432View on ClinicalTrials.gov

High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions

IBDUlcerative ColitisCrohn Disease

Interventions

DRUG

Vitamin D3

Oral Vitamin D3 therapy.

Trial Locations (1)

02115

Boston Children's Hospital, Boston

All Listed Sponsors

lead

Boston Children's Hospital

OTHER